State Attorney General Letitia James is working with drug companies to cap insulin prices for uninsured New Yorkers.
She reached agreements with pharma giants Eli Lilly and Sanofi-Aventis, the nation's largest insulin manufacturers.
Under the terms, the price of insulin will be capped at 35-dollars for a monthly prescription for uninsured New Yorkers for five years.
Both companies also committed to offering free insulin for the neediest patients.
James' office found the prohibitive cost of insulin has caused some New Yorkers to ration their doses or forego them altogether.